Authors/Disclosures
|
Eric Meadows
(Nationwide Children's Hospital)
|
No disclosure on file |
|
Janaiah Kota
(The Research Institute at Nationwide Children)
|
No disclosure on file |
|
Sarah E. Lewis
(Sarepta Therapeutics)
|
Mrs. Lewis has received personal compensation for serving as an employee of Sarepta Therapeutics . Mrs. Lewis has stock in Sarepta Therapeutics. |
|
Zarife F. Sahenk, MD, PhD, FAAN
(The Research Institute at Nationwide Childrens.org)
|
Dr. Sahenk has nothing to disclose. |
|
John M. Bertoni, MD, PhD, FAAN
(University of Nebraska Medical Center)
|
Dr. Bertoni has nothing to disclose. |
|
Reed Clark
|
No disclosure on file |
|
Jerry R. Mendell, MD, FAAN
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |
|
Louise R. Rodino-Klapac
(Sarepta Therapeutics)
|
Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care. |